MDXH, US55278X1072

MDxHealth Stock - Thursday technical snapshot around key support

18.06.2026 - 22:02:25 | ad-hoc-news.de

MDxHealth stock trades near recent lows on Nasdaq, with the chart hovering just above its 52-week floor. Thursday’s technical picture shows subdued volumes and a narrow trading range as investors watch whether support around $0.55 can hold.

MDXH, US55278X1072
MDXH, US55278X1072

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 20:01 UTC. Details in the imprint.

MDxHealth (US55278X1072) trades on Nasdaq via American Depositary Receipts and remains close to its recent lows. With no fresh company news on Thursday, the focus shifts to the stock’s technical picture and how the chart behaves around the $0.55 area.

Go deeper

All news and background on MDxHealth stock

Price data, filings and prior coverage on MDxHealth stock can be found in the dedicated topic hub and on the company’s investor relations pages.

What Thursday’s chart shows

On Thursday the MDxHealth American Depositary Receipts trade around $0.56, only a few cents above their 52-week low of roughly $0.51, according to live quote data from Investing.com. The recent session range has been tight, with intraday levels between about $0.56 and $0.57.

Data from TradingKey show MDxHealth ADRs closing at $0.562 on 06/17/2026, implying a market capitalization of about $28.5 million at that level. The stock has therefore moved in a very narrow band over the past two days, signaling muted short-term momentum.

Focus on support and volatility

From a medium-term perspective MDxHealth shares have retreated sharply from a 52-week high of about $5.33 to the current zone just above $0.50, based on Investing.com’s 12-month range. This leaves the stock trading near multi-year lows and below many common moving-average levels.

Such a compressed price range around key support often coincides with lower realized volatility as traders wait for new fundamental catalysts. Against this backdrop the Thursday picture is primarily a technical one, shaped more by the absence of fresh news than by active re-rating forces.

How MDxHealth makes money

MDxHealth generates revenue from molecular diagnostic tests for urologic cancers, particularly prostate cancer. Its menu includes laboratory-developed assays that help physicians assess cancer risk and support biopsy and treatment decisions, with services reimbursed by health insurers and healthcare providers.

Where the stock trades today

The shares of MDxHealth (US55278X1072) trade on Nasdaq as ADRs at $0.56 as of 06/18/2026, 16:00 ET.

Key facts on MDxHealth stock

  • Company: MDxHealth SA
  • ISIN: US55278X1072
  • WKN: A3EW44
  • Ticker: MDXH
  • Venue: Nasdaq
  • Price (as of 06/18/2026, 16:00 ET): 0.56 USD
  • Market cap: 28.5 million USD (as of 06/18/2026)
  • Sector / Industry: Health Care / Biotechnology & Diagnostics
  • Index membership: none of the major benchmark indices such as the S&P 500 or Nasdaq-100
  • Next earnings date: not officially scheduled

More on MDxHealth stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US55278X1072 | MDXH | boerse | 69576547 | bgmi